PFM Health Sciences’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

PFM Health Sciences’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,583,712	Closed	-$2.25M	–	110
2019 Q2	$2.25M	Sell	2,583,712 -100,966	-4%	-$158K	0.04%	84
2019 Q1	$6.23M	Buy	2,684,678 +1,108,059	+70%	+$3M	0.14%	85
2018 Q4	$3.66M	Buy	1,576,619 +308	+0%	+$2.71K	0.1%	81
2018 Q3	$23.4M	Buy	1,576,311 +25,018	+2%	+$398K	0.34%	84
2018 Q2	$23.6M	Buy	1,551,293 +117	+0%	+$1.99K	0.37%	83
2018 Q1	$29.1M	Sell	1,551,176 -76,966	-5%	-$1.35M	0.59%	61
2017 Q4	$28M	Buy	1,628,142 +47,732	+3%	+$1.01M	0.66%	53
2017 Q3	$35.2M	Buy	+1,580,410	New	+$34.7M	0.69%	50

Other funds holding SNNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

PFM Health Sciences's SNNA Position: Q3 2019 in Review

PFM Health Sciences sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q3 2019, closing a stake of 2,583,712 shares — an estimated $2.25M sold.

PFM Health Sciences first reported a position in SNNA in Q3 2017 and held it in 8 quarters. The position peaked at $35.2M in Q3 2017. 23 funds tracked by Wall St. Rank hold SNNA as of Q3 2019.

PFM Health Sciences reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
PFM Health Sciences sold 2,583,712 Sienna Biopharmaceuticals, Inc. shares in Q3 2019, an estimated $2.25M.
PFM Health Sciences first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2017 and held it in 8 quarters.
PFM Health Sciences's Sienna Biopharmaceuticals, Inc. position peaked at $35.2M in Q3 2017.
23 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q3 2019.

Based on PFM Health Sciences's 13F filing for Q3 2019, filed 14 Nov 2019.